• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.

作者信息

Insogna K L, Mitnick M E, Stewart A F, Burtis W J, Mallette L E, Broadus A E

出版信息

N Engl J Med. 1985 Oct 31;313(18):1126-30. doi: 10.1056/NEJM198510313131805.

DOI:10.1056/NEJM198510313131805
PMID:2995810
Abstract

Previous studies have demonstrated a spectrum of parathyroid responsivity to alterations in the extracellular calcium concentration in patients with primary hyperparathyroidism, but studies employing physiologic amounts of calcium have not, to our knowledge, been reported. We studied 18 unselected patients with primary hyperparathyroidism at the lower (400 mg) and upper (1000 mg) limits of a normal dietary intake of calcium. The diet containing high-normal amounts of calcium induced only a slight increase in 24-hour calcium excretion (from 281 to 337 mg per day) yet was associated with significant reductions in fasting serum levels of immunoreactive parathyroid hormone (from 60 to 50 nleq per milliliter; P less than 0.001), nephrogenous cyclic AMP (from 3.52 to 2.63 nmol per deciliter of glomerular filtrate; P less than 0.001), and plasma levels of 1,25-dihydroxyvitamin D (from 74 to 58 pg per milliliter; P less than 0.001). A wide spectrum of responses was observed, with some patients appearing to have essentially autonomous parathyroid function and others having marked suppressibility (up to 50 per cent) of the parathyroid hormone-vitamin D axis. We conclude that parathyroid function may be suppressed by dietary calcium in some patients with primary hyperparathyroidism.

摘要

相似文献

1
Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
N Engl J Med. 1985 Oct 31;313(18):1126-30. doi: 10.1056/NEJM198510313131805.
2
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.制动状态下的钙稳态:吸收性高钙尿症的一个实例。
N Engl J Med. 1982 May 13;306(19):1136-40. doi: 10.1056/NEJM198205133061903.
3
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.癌症相关性高钙血症患者的生化评估:体液性和非体液性分组的证据
N Engl J Med. 1980 Dec 11;303(24):1377-83. doi: 10.1056/NEJM198012113032401.
4
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.炔雌醇和炔诺酮用于治疗绝经后妇女原发性甲状旁腺功能亢进症。
N Engl J Med. 1986 Jun 5;314(23):1481-5. doi: 10.1056/NEJM198606053142304.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.正常受试者和原发性甲状旁腺功能亢进患者的最大甲状旁腺激素分泌率及钙调定点。体内研究。
Miner Electrolyte Metab. 1988;14(4):221-8.
7
Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women.维生素D摄入量对绝经后女性甲状旁腺激素分泌季节性变化的影响。
N Engl J Med. 1989 Dec 28;321(26):1777-83. doi: 10.1056/NEJM198912283212602.
8
Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?在原发性甲状旁腺功能亢进症中,25-羟基维生素D的血浆浓度是否决定1,25-二羟基维生素D的水平?
Miner Electrolyte Metab. 1996;22(4):203-6.
9
Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.静脉注射钙对肾源性环磷酸腺苷的影响:用作甲状旁腺抑制试验。
J Clin Endocrinol Metab. 1978 Mar;46(3):477-87. doi: 10.1210/jcem-46-3-477.
10
Chronic adaptation of dog parathyroid function to a low-calcium-high-sodium-vitamin D-deficient diet.犬甲状旁腺功能对低钙高钠维生素D缺乏饮食的慢性适应性
J Bone Miner Res. 1992 Sep;7(9):1021-8. doi: 10.1002/jbmr.5650070904.

引用本文的文献

1
Dietary calcium intake in primary hyperparathyroidism and in its normocalcemic variant: a case-control study.原发性甲状旁腺功能亢进及其血钙正常变异型中的膳食钙摄入量:一项病例对照研究。
Front Endocrinol (Lausanne). 2025 Feb 3;15:1428640. doi: 10.3389/fendo.2024.1428640. eCollection 2024.
2
Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population.高钙尿性肾结石人群中正常血钙与高钙血症原发性甲状旁腺功能亢进的比较。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2553-2560. doi: 10.1210/clinem/dgae162.
3
The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.
甲状旁腺激素水平升高的血钙正常患者。
J Endocr Soc. 2023 Jan 26;7(4):bvad013. doi: 10.1210/jendso/bvad013. eCollection 2023 Feb 9.
4
Normocalcemic Hyperparathyroidism: A Heterogeneous Disorder Often Misdiagnosed?血钙正常的甲状旁腺功能亢进症:一种常被误诊的异质性疾病?
JBMR Plus. 2020 Jul 24;4(8):e10391. doi: 10.1002/jbm4.10391. eCollection 2020 Aug.
5
Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism.原发性甲状旁腺功能亢进症甲状旁腺切除术后的临床特征和抑郁评分变化。
Clin Endocrinol (Oxf). 2019 Sep;91(3):464-470. doi: 10.1111/cen.14045. Epub 2019 Jun 25.
6
Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.噻嗪类药物相关高钙血症:二十年间的发病率及与原发性甲状旁腺功能亢进症的关联
J Clin Endocrinol Metab. 2016 Mar;101(3):1166-73. doi: 10.1210/jc.2015-3964. Epub 2016 Jan 11.
7
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.高血压、抗高血压药物与原发性甲状旁腺功能亢进症发病风险
J Clin Endocrinol Metab. 2015 Jun;100(6):2396-404. doi: 10.1210/jc.2015-1619. Epub 2015 Apr 17.
8
Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.意大利内分泌学会共识声明:轻度原发性甲状旁腺功能亢进症患者的定义、评估与管理
J Endocrinol Invest. 2015 May;38(5):577-93. doi: 10.1007/s40618-015-0261-3. Epub 2015 Mar 28.
9
Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).五十年间(1965 - 2010年)原发性甲状旁腺功能亢进发病率的长期趋势。
Bone. 2015 Apr;73:1-7. doi: 10.1016/j.bone.2014.12.003. Epub 2014 Dec 11.
10
Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism.绝经后原发性甲状旁腺功能亢进症妇女长期维生素 D 治疗。
Endocr Connect. 2012 Jun 8;1(1):13-21. doi: 10.1530/EC-12-0008. Print 2012 Jul 1.